MedTrace Logo

Biodentine Versus White MTA Pulpotomy

NCT01733420 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2021-11-22

No results posted yet for this study

Summary

A clinical trial to evaluate and compare three different products used for endodontic treatment (taking the infected nerve out of the teeth) of primary teeth.

Null Hypothesis: The new biological products (WMTA and Biodentine) behave as good as the former iodoform product.

Conditions

  • Extensive Decay in Primary Molars

Interventions

DRUG

Biodentine pulpotomy

DRUG

White MTA pulpotomy

DRUG

Tempophore pulpotomy

Sponsors & Collaborators

  • University Ghent

    lead OTHER

Principal Investigators

  • Luc Martens, PhD, DDS · University Ghent

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-04
Primary Completion
2015-11-30
Completion
2016-02-29

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01733420 on ClinicalTrials.gov